Brown Brothers Harriman & Co. Sells 788 Shares of CME Group Inc. (NASDAQ:CME)

Brown Brothers Harriman & Co. lowered its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 9.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,973 shares of the financial services provider’s stock after selling 788 shares during the period. Brown Brothers Harriman & Co.’s holdings in CME Group were worth $1,852,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. SJS Investment Consulting Inc. lifted its holdings in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares during the last quarter. Dunhill Financial LLC lifted its stake in CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares during the last quarter. New Age Alpha Advisors LLC lifted its stake in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares during the last quarter. Financial Life Planners bought a new stake in shares of CME Group during the fourth quarter worth $32,000. Finally, Knuff & Co LLC acquired a new position in shares of CME Group during the fourth quarter worth $33,000. 87.75% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on CME shares. Keefe, Bruyette & Woods boosted their price objective on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Piper Sandler boosted their price target on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Royal Bank of Canada raised their price objective on shares of CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a report on Thursday, February 13th. Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a report on Monday, March 17th. Finally, JPMorgan Chase & Co. lifted their target price on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $238.93.

Check Out Our Latest Stock Report on CME Group

Insiders Place Their Bets

In other news, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the transaction, the director now owns 21,873 shares in the company, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the sale, the insider now directly owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This trade represents a 34.63 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 27,076 shares of company stock valued at $6,871,496. 0.30% of the stock is currently owned by corporate insiders.

CME Group Price Performance

CME opened at $262.22 on Friday. The firm has a 50-day moving average of $249.65 and a 200 day moving average of $235.75. The firm has a market cap of $94.49 billion, a P/E ratio of 27.12, a PEG ratio of 6.76 and a beta of 0.53. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $267.91. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were given a dividend of $1.25 per share. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date was Friday, March 7th. CME Group’s dividend payout ratio (DPR) is presently 51.71%.

CME Group announced that its Board of Directors has authorized a stock buyback plan on Thursday, December 5th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.